Is TKBIF or HDV a better dividend investment in 2026?

TKBIF currently yields 1.58% with a 5% 5-year dividend growth rate. HDV yields 2.92% with 4.8% growth. The better choice depends on your goal: HDV offers higher current income.

What is the dividend yield difference between TKBIF and HDV?

TKBIF has a forward dividend yield of 1.58% ($0.12/share annually). HDV yields 2.92% ($3.96/share annually). The yield gap is 1.34 percentage points.

Home › Compare › TKBIF vs HDV

TKBIF vs HDV: Dividend Comparison 2026

TKBIF yields 1.58% · HDV yields 2.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HDV wins by $2.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

TKBIF

● Live price

1.58%

Share price

$7.30

Annual div

$0.12

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.0K

Annual income

$174.62

Full TKBIF calculator →

HDV

iShares Core High Dividend ETF

● Live price

2.92%

Share price

$135.39

Annual div

$3.96

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.3K

Annual income

$352.73

Full HDV calculator →

Portfolio growth — TKBIF vs HDV

📍 HDV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TKBIF	HDV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TKBIF + HDV cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TKBIF pays

HDV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TKBIF

Annual income on $10K today (after 15% tax)

$134.02/yr

After 10yr DRIP, annual income (after tax)

$148.43/yr

HDV

Annual income on $10K today (after 15% tax)

$248.52/yr

After 10yr DRIP, annual income (after tax)

$299.82/yr

At 15% tax rate, HDV beats the other by $151.39/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TKBIF + HDV for your $10,000?

TKBIF: 50%HDV: 50%

100% HDV50/50100% TKBIF

Portfolio after 10yr

$23.1K

Annual income

$263.67/yr

Blended yield

1.14%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TKBIF buys

HDV buys

No recent congressional trades found for TKBIF or HDV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTKBIFHDV

Forward yield	1.58%	2.92% ✓
Annual dividend / share	$0.12	$3.96 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$22.0K	$24.3K ✓
Annual income after 10y	$174.62	$352.73 ✓
Total dividends collected	$1.7K	$3.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: TKBIF vs HDV ($10,000, DRIP)

Year	TKBIF Portfolio	TKBIF Income/yr	HDV Portfolio	HDV Income/yr	Gap
1← crossover	$10,858	$157.67	$11,002	$292.38	$144.00 → HDV
2	$11,778	$159.99	$12,084	$300.36	$306.00 → HDV
3	$12,764	$162.20	$13,250	$308.02	$486.00 → HDV
4	$13,822	$164.29	$14,506	$315.35	$684.00 → HDV
5	$14,956	$166.26	$15,858	$322.35	$902.00 → HDV
6	$16,171	$168.13	$17,313	$329.04	$1.1K → HDV
7	$17,473	$169.90	$18,878	$335.42	$1.4K → HDV
8	$18,868	$171.57	$20,560	$341.49	$1.7K → HDV
9	$20,361	$173.14	$22,367	$347.25	$2.0K → HDV
10	$21,961	$174.62	$24,307	$352.73	$2.3K → HDV

TKBIF vs HDV: Complete Analysis 2026

TKBIF — Stock

Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names. It also provides contract services for regenerative medicine products, such as manufacturing of viral vectors and gene-transduced cells, quality and safety testing, and cell banking; and contract services for gene analysis and testing, including sequencing, intestinal flora analysis, comprehensive analysis of cancer-associated genes, and cell line creation through genome editing. In addition, the company is involved in developing platform technology for biologics development in areas, such as gene therapy. The company was incorporated in 2002 and is based in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.

Full TKBIF Calculator →

HDV — ETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →

📬

Get this TKBIF vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TKBIF vs SCHD TKBIF vs JEPI TKBIF vs O TKBIF vs KO TKBIF vs MAIN TKBIF vs VYM TKBIF vs DVY TKBIF vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.